People News

Share this article:

Xanodyne Pharmaceuticals, a specialty pharma focused on women's healthcare and pain management, announced the appointment of Michael Valentino to president and CEO. Valentino was previously president and CEO at Adams Laboratories. Before that, he was EVP, global head, consumer pharmaceuticals at Novartis.

 

Astellas hired Betsy Garofalo as global therapy leader for its central nervous system (CNS) group. Garofalo, a pediatric neurologist and epileptologist, will “provide strategic direction and leadership for the development of all Astellas CNS compounds,” said Steven Ryder, president of Astellas Pharma Global Development, in a statement. Garofalo is an adjunct associate professor of pediatrics at the University of Michigan, and has previously worked at Pfizer R&D, and Parke-Davis.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media